Literature DB >> 29581686

The Charlson Comorbidity Index as an Independent Prognostic Factor in Older Colorectal Cancer Patients.

Tetsuro Tominaga1, Takashi Nonaka1, Hiroaki Takeshita1, Masaki Kunizaki1, Yorihisa Sumida1, Shigekazu Hidaka1, Terumitsu Sawai2, Takeshi Nagayasu1.   

Abstract

High-age patients have higher rates of comorbidity that are associated with a poor prognosis. It is important to correctly evaluate their preoperative status to avoid mortality. The aim of this study was to clarify whether the Charlson comorbidity index (CCI) was useful for predicting postoperative outcomes. This retrospective study collected data from 250 consecutive patients over 75 years of age. The CCI takes into account 19 comorbid conditions. Inflammation-based scores, including the Glasgow prognostic score (GPS) and the platelet to lymphocyte ratio (PLR), are other preoperative scoring systems. The relationships among these scores and postoperative outcomes were evaluated. The patients were classified according to their vital status (dead, n = 30 or alive, n = 220). Comorbidities, the presence of double cancer, and lymph node metastases were significantly different between the groups (p < 0.01, p = 0.01, and p < 0.01). In regard to the scoring systems, the CCI, GPS, and PLR were significantly different (p = 0.02, p = 0.03, and p = 0.05). Multivariate analysis identified CCI ≥ 2 (hazard ratio (HR) = 5.24, 95 % confidence interval (CI) = 1.30-12.1, p = 0.01) as a significant determinant of postoperative outcome (p < 0.01). The overall survival tended to be lower in patients with high CCI scores group (p = 0.03). The CCI was useful to predict postoperative outcomes in high-age colorectal cancer patients.

Entities:  

Keywords:  Charlson comorbidity index; Colorectal cancer; Older patients; Overall survival

Year:  2016        PMID: 29581686      PMCID: PMC5866797          DOI: 10.1007/s12262-016-1544-4

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  29 in total

Review 1.  Platelets: linking hemostasis and cancer.

Authors:  Shashank Jain; John Harris; Jerry Ware
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

2.  POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity.

Authors:  D R Prytherch; M S Whiteley; B Higgins; P C Weaver; W G Prout; S J Powell
Journal:  Br J Surg       Date:  1998-09       Impact factor: 6.939

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.

Authors:  Donald C McMillan; Joseph E M Crozier; Khalid Canna; Wilson J Angerson; Colin S McArdle
Journal:  Int J Colorectal Dis       Date:  2007-01-24       Impact factor: 2.571

5.  Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery.

Authors:  Y Haga; S Ikei; M Ogawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

6.  Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.

Authors:  Cheng-Chih Chang; Chien-Feng Sun; Hung-Jia Pai; Wen-Ke Wang; Ching-Chuan Hsieh; Liang-Mou Kuo; Chia-Siu Wang
Journal:  Chang Gung Med J       Date:  2010 May-Jun

7.  Determining the C-reactive protein level in patients with different clinical forms of chagas disease.

Authors:  Conceição Aparecida da Silva; André Fattori; Aglécio L Sousa; Sílvia B Mazon; Sarah Monte Alegre; Eros A Almeida; Maria E Guariento
Journal:  Rev Esp Cardiol       Date:  2010-09       Impact factor: 4.753

8.  Worldwide variation in life-span sexual dimorphism and sex-specific environmental mortality rates.

Authors:  Anatoly T Teriokhin; Elena V Budilova; Frederic Thomas; Jean-Francois Guegan
Journal:  Hum Biol       Date:  2004-08       Impact factor: 0.553

9.  Systemic inflammatory response predicts survival following curative resection of colorectal cancer.

Authors:  D C McMillan; K Canna; C S McArdle
Journal:  Br J Surg       Date:  2003-02       Impact factor: 6.939

10.  Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation.

Authors:  Chin-Chia Wu; Ta-Wen Hsu; Chun-Ming Chang; Chia-Hui Yu; Ching-Chih Lee
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

View more
  7 in total

1.  Long-term outcomes and prognostic factors with non-curative endoscopic submucosal dissection for gastric cancer in elderly patients aged ≥ 75 years.

Authors:  Yosuke Toya; Masaki Endo; Shotaro Nakamura; Risaburo Akasaka; Shunichi Yanai; Keisuke Kawasaki; Keisuke Koeda; Makoto Eizuka; Yasuko Fujita; Noriyuki Uesugi; Kazuyuki Ishida; Tamotsu Sugai; Takayuki Matsumoto
Journal:  Gastric Cancer       Date:  2018-12-17       Impact factor: 7.370

2.  Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease.

Authors:  Hiroyuki Yagyu; Kota Murohashi; Yu Hara; Yusuke Saigusa; Ayako Aoki; Nobuaki Kobayashi; Takeshi Kaneko
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

3.  Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

Authors:  Kota Murohashi; Yu Hara; Yusuke Saigusa; Nobuaki Kobayashi; Takashi Sato; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

4.  Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.

Authors:  Xin Lu; Wanying Guo; Wei Xu; Xuelei Zhang; Zhijie Shi; Leizhen Zheng; Wenzhao Zhao
Journal:  Cancer Manag Res       Date:  2018-12-24       Impact factor: 3.989

5.  How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010-2016.

Authors:  Giulia Scondotto; Janet Sultana; Valentina Ientile; Ylenia Ingrasciotta; Andrea Fontana; Massimiliano Copetti; Eliana Mirabelli; Costantino J Trombetta; Carlo Rapisarda; Michele Reibaldi; Teresio Avitabile; Antonio Longo; Patricia Ibanez Toro; Maria Vadalà; Salvatore Cillino; Gianni Virgili; Rosa Gini; Olivia Leoni; Sebastiano Walter Pollina Addario; Pasquale Cananzi; Claudia La Cavera; Maria Rosalia Puzo; Giovambattista De Sarro; Adele De Francesco; Gianluca Trifirò
Journal:  Biomed Res Int       Date:  2020-01-11       Impact factor: 3.411

6.  The impact of comorbidities on post-operative complications following colorectal cancer surgery.

Authors:  David E Flynn; Derek Mao; Stephanie T Yerkovich; Robert Franz; Harish Iswariah; Andrew Hughes; Ian M Shaw; Diana P L Tam; Manju D Chandrasegaram
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

7.  Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study.

Authors:  Sophia Scharl; Tim Sprötge; Michael Gerken; Anton Scharl; Atanas Ignatov; Elisabeth C Inwald; Olaf Ortmann; Oliver Kölbl; Monika Klinkhammer-Schalke; Thomas Papathemelis
Journal:  Arch Gynecol Obstet       Date:  2021-07-05       Impact factor: 2.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.